Judith Bellmann–Strobl

7.7k total citations · 2 hit papers
139 papers, 4.0k citations indexed

About

Judith Bellmann–Strobl is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, Judith Bellmann–Strobl has authored 139 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 114 papers in Pathology and Forensic Medicine, 51 papers in Neurology and 31 papers in Rheumatology. Recurrent topics in Judith Bellmann–Strobl's work include Multiple Sclerosis Research Studies (109 papers), Peripheral Neuropathies and Disorders (26 papers) and Systemic Lupus Erythematosus Research (26 papers). Judith Bellmann–Strobl is often cited by papers focused on Multiple Sclerosis Research Studies (109 papers), Peripheral Neuropathies and Disorders (26 papers) and Systemic Lupus Erythematosus Research (26 papers). Judith Bellmann–Strobl collaborates with scholars based in Germany, United States and Switzerland. Judith Bellmann–Strobl's co-authors include Friedemann Paul, Alexander U. Brandt, Klemens Ruprecht, Frauke Zipp, Jan Dörr, Michael Scheel, Jens Wuerfel, Hanna Zimmermann, Claudia Chien and Orhan Aktaş and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nature Communications.

In The Last Decade

Judith Bellmann–Strobl

131 papers receiving 4.0k citations

Hit Papers

A prospective observational study of post-COVID-19 chroni... 2022 2026 2023 2024 2022 2022 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity
    2022 169 citations Claudia Kedor, Helma Freitag et al. Nature Communications profile →
  2. Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS)
    2022 168 citations Helma Freitag, Gordon Rudolf et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Judith Bellmann–Strobl Germany 38 2.4k 1.4k 728 623 542 139 4.0k
Jan Dörr Germany 36 1.8k 0.7× 631 0.4× 432 0.6× 1.0k 1.6× 464 0.9× 76 3.3k
Alexander U. Brandt Germany 46 3.2k 1.3× 1.8k 1.2× 1.1k 1.5× 1.9k 3.1× 674 1.2× 190 5.8k
Teresa C. Frohman United States 36 2.8k 1.1× 1.0k 0.7× 881 1.2× 2.4k 3.8× 508 0.9× 111 4.8k
Nynke F. Kalkers Netherlands 26 2.9k 1.2× 1.2k 0.9× 742 1.0× 152 0.2× 394 0.7× 40 3.4k
Ahmed Toosy United Kingdom 33 1.9k 0.8× 974 0.7× 470 0.6× 569 0.9× 490 0.9× 88 3.5k
Carlos Nos Spain 34 3.3k 1.4× 1.6k 1.1× 1.2k 1.6× 123 0.2× 553 1.0× 71 4.1k
Lawrence Jacobs United States 28 2.3k 0.9× 1.3k 0.9× 809 1.1× 188 0.3× 342 0.6× 56 3.6k
Robert Bermel United States 30 1.9k 0.8× 617 0.4× 519 0.7× 200 0.3× 483 0.9× 84 2.7k
Paolo Preziosa Italy 32 2.9k 1.2× 1.1k 0.8× 612 0.8× 83 0.1× 651 1.2× 143 4.2k
Con Yiannikas Australia 38 1.4k 0.6× 1.8k 1.2× 494 0.7× 778 1.2× 521 1.0× 142 3.8k

Countries citing papers authored by Judith Bellmann–Strobl

Since Specialization
Citations

This map shows the geographic impact of Judith Bellmann–Strobl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith Bellmann–Strobl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith Bellmann–Strobl more than expected).

Fields of papers citing papers by Judith Bellmann–Strobl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith Bellmann–Strobl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith Bellmann–Strobl. The network helps show where Judith Bellmann–Strobl may publish in the future.

Co-authorship network of co-authors of Judith Bellmann–Strobl

This figure shows the co-authorship network connecting the top 25 collaborators of Judith Bellmann–Strobl. A scholar is included among the top collaborators of Judith Bellmann–Strobl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith Bellmann–Strobl. Judith Bellmann–Strobl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gómez‐Figueroa, Enrique, Priscilla Bäcker‐Koduah, Jan Dörr, et al.. (2025). Neuroprotective role of high dose Vitamin D supplementation in multiple sclerosis: Sub-analysis of the EVIDIMS trial. Multiple Sclerosis and Related Disorders. 101. 106567–106567.
2.
Meyer‐Arndt, Lil, Claudia Kedor, Kirsten Wittke, et al.. (2025). Functional olfactory impairment and fatigue in post-COVID-19 syndrome including ME/CFS – a longitudinal prospective observational study. Brain Behavior & Immunity - Health. 50. 101124–101124.
3.
Fernández‐Zapata, Camila, Maya Golan, Leif Erik Sander, et al.. (2023). Associations of myeloid cells with cellular and humoral responses following vaccinations in patients with neuroimmunological diseases. Nature Communications. 14(1). 7728–7728. 2 indexed citations
4.
Bellmann–Strobl, Judith, Peter Flachenecker, Insa Schiffmann, et al.. (2023). Translation and validation of the multiple sclerosis walking scale 12 for the German population – the MSWS-12/D. Health and Quality of Life Outcomes. 21(1). 110–110. 5 indexed citations
5.
Meyer‐Arndt, Lil, Claudia Kedor, Helma Freitag, et al.. (2023). Long-term symptom severity and clinical biomarkers in post-COVID-19/chronic fatigue syndrome: results from a prospective observational cohort. EClinicalMedicine. 63. 102146–102146. 52 indexed citations
6.
Meyer‐Arndt, Lil, Judith Bellmann–Strobl, Lukas Maurer, et al.. (2023). Body mass, neuro-hormonal stress processing, and disease activity in lean to obese people with multiple sclerosis. Journal of Neurology. 271(4). 1584–1598. 2 indexed citations
7.
Kedor, Claudia, Helma Freitag, Lil Meyer‐Arndt, et al.. (2022). A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nature Communications. 13(1). 5104–5104. 169 indexed citations breakdown →
8.
Papadopoulou, Athina, Frederike Cosima Oertel, Claudia Chien, et al.. (2021). Lateral geniculate nucleus volume changes after optic neuritis in neuromyelitis optica: A longitudinal study. NeuroImage Clinical. 30. 102608–102608. 9 indexed citations
9.
Asseyer, Susanna, Hiroki Masuda, Masahiro Mori, et al.. (2021). AQP4-IgG autoimmunity in Japan and Germany: Differences in clinical profiles and prognosis in seropositive neuromyelitis optica spectrum disorders. Multiple Sclerosis Journal - Experimental Translational and Clinical. 7(2). 3080370062–3080370062. 6 indexed citations
10.
Oertel, Frederike Cosima, Susanna Asseyer, Rebekka Rust, et al.. (2021). Impaired motion perception is associated with functional and structural visual pathway damage in multiple sclerosis and neuromyelitis optica spectrum disorders. Multiple Sclerosis Journal. 28(5). 757–767. 5 indexed citations
11.
Rust, Rebekka, Claudia Chien, Michael Scheel, et al.. (2021). Epigallocatechin Gallate in Progressive MS. Neurology Neuroimmunology & Neuroinflammation. 8(3). 19 indexed citations
12.
Motamedi, Seyedamirhosein, Frederike Cosima Oertel, Sunil Kumar Yadav, et al.. (2020). Altered fovea in AQP4-IgG–seropositive neuromyelitis optica spectrum disorders. Neurology Neuroimmunology & Neuroinflammation. 7(5). 35 indexed citations
13.
Dörr, Jan, Priscilla Bäcker‐Koduah, Klaus‐Dieter Wernecke, et al.. (2020). High-dose vitamin D supplementation in multiple sclerosis – results from the randomized EVIDIMS (efficacy of vitamin D supplementation in multiple sclerosis) trial. Multiple Sclerosis Journal - Experimental Translational and Clinical. 6(1). 2455323442–2455323442. 35 indexed citations
14.
Bäcker‐Koduah, Priscilla, Carmen Infante‐Duarte, Federico Ivaldi, et al.. (2020). Effect of vitamin D supplementation on N‐glycan branching and cellular immunophenotypes in MS. Annals of Clinical and Translational Neurology. 7(9). 1628–1641. 8 indexed citations
15.
Asseyer, Susanna, Michael Scheel, Nadja Siebert, et al.. (2020). Evaluation of the ‘ring sign’ and the ‘core sign’ as a magnetic resonance imaging marker of disease activity and progression in clinically isolated syndrome and early multiple sclerosis. Multiple Sclerosis Journal - Experimental Translational and Clinical. 6(1). 2455335448–2455335448. 32 indexed citations
16.
Grittner, Ulrike, René M. Gieß, Michael Scheel, et al.. (2019). Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosis. Neurology. 93(15). e1439–e1451. 35 indexed citations
17.
Kuchling, Joseph, Yael Backner, Frederike Cosima Oertel, et al.. (2018). Comparison of probabilistic tractography and tract-based spatial statistics for assessing optic radiation damage in patients with autoimmune inflammatory disorders of the central nervous system. NeuroImage Clinical. 19. 538–550. 37 indexed citations
18.
Hasselmann, Helge, Judith Bellmann–Strobl, Roland Ricken, et al.. (2016). Characterizing the phenotype of multiple sclerosis–associated depression in comparison with idiopathic major depression. Multiple Sclerosis Journal. 22(11). 1476–1484. 30 indexed citations
19.
Pfueller, Caspar F., Alexander U. Brandt, Markus Böck, et al.. (2011). Metabolic Changes in the Visual Cortex Are Linked to Retinal Nerve Fiber Layer Thinning in Multiple Sclerosis. PLoS ONE. 6(4). e18019–e18019. 67 indexed citations
20.
Böck, Markus, Alexander U. Brandt, Jan Dörr, et al.. (2010). Patterns of retinal nerve fiber layer loss in multiple sclerosis patients with or without optic neuritis and glaucoma patients. Clinical Neurology and Neurosurgery. 112(8). 647–652. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jan Dörr Breakdown of academic impact, for papers by Alexander U. Brandt Breakdown of academic impact, for papers by Teresa C. Frohman Breakdown of academic impact, for papers by Nynke F. Kalkers Breakdown of academic impact, for papers by Ahmed Toosy Breakdown of academic impact, for papers by Carlos Nos Breakdown of academic impact, for papers by Lawrence Jacobs Breakdown of academic impact, for papers by Robert Bermel Breakdown of academic impact, for papers by Paolo Preziosa Breakdown of academic impact, for papers by Con Yiannikas
Rankless by CCL
2026